Effects of Janus kinase inhibition and interleukin 6 inhibition on serum cytokine/chemokine in idiopathic multicentric Castleman disease.

Jyseleca (filgotinib) - Gilead

Actemra IV (tocilizumab) - Roche, JW Pharma

http://www.ncbi.nlm.nih.gov/pubmed/41922262

Atsushi Katsube; Atsushi Kawakami; Naoki Hosogaya; Osamu Kamisawa; Remi Sumiyoshi; Rieko Kiya; Sawana Narita; Shimpei Morimoto; Shingo Yano; Shoichi Fukui; Tomohiro Koga

Apr 2, 2026